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MicroRNAs, small non-coding RNAs which act as repressors of target genes, were discovered in 1993,
and since then have been shown to play important roles in the development of numerous systems.
Consistent with this role, they are also implicated in the pathogenesis of multiple diseases. Here we
review the involvement of microRNAs in mouse development and disease, with particular reference to
deafness as an example.
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. Introduction
MicroRNAs are small non-coding RNAs which negatively reg-
late speciﬁc target genes by mRNA degradation or translational
epression, and they arenumerous throughout the genomesof both
nimals and plants. They demonstrate a range of spatial and tem-
oral expression patterns, and have proven to play multiple roles
n a variety of processes. The ﬁrst microRNA identiﬁed, the lin-
locus in the nematode worm Caenorhabditis elegans, was found
ecause mutations cause abnormal cell division and proliferation,
which lin-4 was known to negatively regulate [2]. It was 7 years
before the second small regulatory RNA was found: let-7, also in C.
elegans. Like lin-4, let-7 controls cell fate and timing; loss of the gene
causes defects during moulting where cells failed to achieve adult
identities. Overexpression of let-7 has the opposite effect; cells dif-
ferentiate too early [3]. Homologues of let-7were found inmultiple
lineages, from vertebrates to arthropods, and expression of let-7 in
zebraﬁsh and fruit ﬂy was limited to late stages in development.
It was therefore suggested that these ‘small temporal RNAs’ might
Open access under CC BY license.nd also affect the timing of cell division and development in larvae
1]. When the gene responsible was cloned, rather than a protein-
oding gene, it was found to code for a small RNA that bound to and
ownregulated the messenger RNA of another gene named lin-14,
∗ Corresponding author. Tel.: +44 1223 495379; fax: +44 1223 494919.
E-mail addresses: ml7@sanger.ac.uk (M.A. Lewis), kps@sanger.ac.uk (K.P. Steel).
084-9521© 2010 Elsevier Ltd. 
oi:10.1016/j.semcdb.2010.02.004
Open access under CC BY license. play a role in the timing of developmental transitions [4].
It is now known that microRNAs have far more roles than just
timing developmental transitions, and they are present in multiple
species, including plants, animals and even an alga, implying that
the regulation of genes by RNA silencing is an ancient mechanism
[5]. Like let-7, homologues of somemicroRNA families can be found
in deuterostomes and protostomes, while some are more speciﬁc,
such as Mir196, which is limited to vertebrate species, having no
close orthologues in invertebrates, although it is related distantly
& Developmental Biology 21 (2010) 774–780 775
t
m
a
[
i
e
2
o
c
l
c
m
b
d
m
m
i
p
g
t
p
b
c
t
e
v
s
a
3
f
m
o
f
e
w
m
t
a
g
g
i
m
t
F
r
m
g
[
i
s
m
a
u
t
w
m
o
Fig. 1. Cartoon showing putative mechanisms of microRNA repression. The
microRNA is represented by a thick red block over the violet line, which is the tar-
get mRNA. The blue hexagon represents the translation initiation complex and the
orange circles ribosomes. (A) Perfect binding ofmiRNA to targetmRNA and cleavageM.A. Lewis, K.P. Steel / Seminars in Cell
o let-7 [6]. Mir196 is found in the lamprey, a jawless ﬁsh, which
eans it must have arisen before the divergence of the agnathans
nd the gnathostomes, a very early event in the vertebrate lineage
7]. miR-196a cleaves the transcript of the homeobox gene Hoxb8
n mouse embryos, important in specifying regional identity in the
mbryo [8–10].
. Expression patterns of microRNAs and their targets
Many more microRNAs are known to be expressed through-
ut development, so much so that it has been suggested that each
ell type has its own microRNA expression proﬁle, and dynamic,
ocalised expression of any gene during the development of a spe-
iﬁc system implies a function for that gene [11]. For example,
icroRNA expression has been shown to vary dynamically in the
rain both before and after birth, indicating a requirement for
ifferent microRNAs at different time points [12]. Likewise, the
icroRNA Mir133 is known to be speciﬁcally expressed in the
ouse embryonic heart and skeletal muscle from E12 onwards,
mplying a role in mid-gestation development of these tissues [13].
The microRNA expression proﬁle is only one part of the jigsaw
uzzle; a microRNA may be present ubiquitously, but if its target
ene is only expressed in a small subset of cells, then that is where
hat microRNA will exert its effects. The importance of expression
atterns of both the microRNAs and their targets can be illustrated
y miR-1, which is expressed in embryonic heart and skeletal mus-
le. Hdac4 is a repressor of muscle differentiation, and miR-1 is
hought to targetHdac4 inmuscles and thuspromotemusclediffer-
ntiation [14]. In the heart, however, miR-1 is required to regulate
entricular cardiomyocytes through repressing the cardiac tran-
cription factor Hand2; Mir1 overexpression results in heart failure
t about E13.5, due to a failure in proliferation [15].
. MicroRNAs have many targets
The identiﬁcation of target genes is, of course, very important
or understanding how microRNAs operate. So far, many of the
icroRNA studies that have been carried out have concentrated
n the effect of the particular microRNA on a single gene or just a
ew genes. For example, results fromexperimentalmanipulation of
xpressionofmiR-150and itsmost likely target gene,Myb, together
ith the observation of adverse effects of the systemic knockout of
iR-150 on a single cell type only, the mature lymphocyte, suggest
hat themain role of thismicroRNAmaybemediated through inter-
ction with a single target gene in a single cell type [16]. Similarly,
enetic manipulation of both miR-223 and its most likely target
ene, Mef2c, suggested that this microRNA acted primarily through
ts interaction with Mef2c in early myeloid progenitors [17].
However, bioinformatic analyses predict hundreds of targets for
ammalian microRNAs, and it seems likely that many are genuine
argets [18]. This is backedupbymultiple studies in vivoand in vitro.
or example, mice null for Mir223 show derepression of a wide
ange of both proteins and mRNAs, which in turn indicates that
icroRNAs in animals may operate by the degradation of messen-
er RNA, prevention of protein translation or a combination of both
19] (Fig. 1). A second example is the mutant lacking Mir155, which
s immunodeﬁcient and displays lung and airway remodelling and
hows awide range of genes upregulated in their Th1 and Th2 cells,
anyofwhicharepredicted targets ofmiR-155 [20]. Thirdly,miR-1
nd miR-124, when transfected into human cells, cause downreg-
lation of about 100 messages each [21]. A fourth example is the
ransfection of several human microRNAs into HeLa cells, each of
hich led to downregulation of hundreds of mRNAs together with
odest reduction in protein levels [22]. Finally, our own analysis
f the impact of a mutation affecting miR-96 on mRNA expressionof mRNA followed by degradation. (B) Inhibition of translation initiation. (C) Inhibi-
tionof elongation/terminationandpromotionof ribosomedrop-off. (D)Recruitment
of a proteolytic enzyme to degrade emerging polypeptides. (E) Deadenylation, fol-
lowed by degradation, of the mRNA [78,79].
in the inner ear indicates that many hundreds of transcripts are
affected (see later) [23].
It has been suggested that microRNAs exert both absolute and
ﬁne-tuned control of gene expression, adjusting levels of tran-
scripts to give either completeor simplydecreased repression. Such
‘ﬁne-tuning’ microRNAs are likely to be harder to identify than
those operating by ‘switching off’ a gene, since loss of function of
any one of them would be predicted to have subtle effects that are
hard to characterise and study [24].
4. MicroRNAs in early mouse development and cancer
In the mouse zygote, maternally inherited microRNAs are abun-
dant, with a dynamic expression proﬁle; some are downgraded
by as much as 95% between the one- and two-cell stages. Zygotic
transcription ofmicroRNAs begins from the two-cell stage. Oocytes
lacking Dicer, a gene required for microRNA processing and essen-
tial for mouse development [25], lack maternal microRNAs and fail
to pass the ﬁrst cell division [26,27]. One of the many microRNAs
expressed from the two-cell stage is Mir125a, an orthologue of C.
elegans lin-4. Its expression increases between the two-cell and
blastocyst stages, and it is thought that itmayhave a role in control-
ling early embryonic timing through regulationof thegenePed [28].
Mir93, a member of the miR-17 family, is speciﬁcally expressed in
the trophoectoderm and future primitive endoderm, in a pattern
complementary to that of the gene Stat3, which is important for
early development [29,30]. miR-93 has been shown to bind to and
downregulate Stat3 mRNA during ES cell differentiation [29].
7 & Dev
s
c
m
c
t
a
r
h
i
d
5
h
c
w
r
f
c
d
m
o
c
m
a
j
c
e
g
u
w
d
6
s
o
s
a
h
t
l
r
m
i
M
c
v
m
p
t
f
b
d
f
l
m
m
a
i
s
rather than inactivationof theEgﬂ7gene, by selectively inactivating
either miR-126 or Egﬂ7 [50,51]. Both Egﬂ7 and Mir126 are widely
expressed in endothelial cells, and their close genomic localisation
may facilitate this co-expression [50]. Two further examples are76 M.A. Lewis, K.P. Steel / Seminars in Cell
It is common for genes controlling developmental processes
uch as cell proliferation and differentiation to be associated with
ancer, and many microRNAs are implicated in tumour develop-
ent andprogression,with a signiﬁcant number ofmiRNAs located
lose to tumour susceptibility loci inmice [31]. ThemiR-17–92clus-
er, for example, is required for proper development of the heart
nd lung, and also that of foetal and adult B cells, possibly through
egulationof thepro-apoptotic geneBim [32,33]. Itwasﬁrst known,
owever, for its role in cancer; overexpression of part of the cluster
n a mouse B-cell lymphoma model causes acceleration of tumour
evelopment [34].
. MicroRNA expression proﬁles in disease
Comparison of microRNA expression proﬁles in diseased and
ealthy tissues has shown the diseased state to be associated with
hanges in the expression levels of many different miRNAs, and
e give just a few examples. The miRNA expression proﬁle of the
etinas of mice with retinitis pigmentosa showed signiﬁcant dif-
erences comparedwithwildtype retinas, implying thatmicroRNAs
ould play a role in retinal disease [35].MicroRNA expression in the
iaphragm of a dystrophin-deﬁcient mouse, a model for Duchenne
uscular dystrophy, revealed a dramatic increase in expression
f the muscle-speciﬁc microRNA Mir206 [36], while skeletal mus-
le hypertrophy induced by functional overloading of the plantaris
uscle results in downregulation of miR-1 and miR-133a, which
re also muscle-speciﬁc miRNAs [37]. In a third example, mice sub-
ected to thoracic aortic banding, which in wildtype mice induces
ardiac hypertrophy, revealed over 100 miRNAs with differential
xpression compared to control mice [38]. The most upregulated
ene in this conditionwasMir21.WhenmiR-21was knocked down
sing an antisense approach in vitro, cardiomyocyte hypertrophy
as reduced, suggesting it has a key role in the mechanism of car-
iac hypertrophy [38].
. Mouse knockouts demonstrate the importance of
peciﬁc microRNAs
Knockouts are of course very important for studying the role
f a gene in pathogenesis. For example, knockouts have demon-
trated that several microRNAs are required for heart development
nd function. Mice null for both miR-133a-1 and miR-133a-2
ave larger ventricular chambers, and thinner ventricular walls
han controls, and proved to have aberrant cardiomyocyte pro-
iferation and apoptosis [39]. miR-208 knockout mice display a
educed hypertrophic response to thoracic aortic banding, and this
icroRNA is thought to regulate stress-dependent gene expression
n the heart [40] and is required for normal cardiac conduction [41].
ice lacking miR-1-2 have defects in cardiac morphogenesis and
onduction [42]. miR-17–92 knockout mutants died at birth with a
entricular septal defect as well as hypoplastic lungs [33].
Targeted microRNA knockouts have not been limited to those
icroRNAs involved in heart development and function. For exam-
le, Dnmos3, a non-coding RNA transcript which is processed into
hree microRNAs, miR-199a, miR-199a* and miR-214, is expressed
rom E9.5 in multiple locations and knockouts show reduced via-
ility and skeletal defects, with shortened heads, osteopenia, and
efects in the neural arch and spinous process [43]. Mice null
or miR-143 and miR-145 demonstrate dedifferentiation of vascu-
ar smooth muscle cells, implying a role for those microRNAs in
aturation and differentiation of these cells [44,45]. Intriguingly,
iR-143 and miR-145 have been found to be deregulated in aortic
neurysms in humans [46]. Mir155 knockout mice display enteric
nﬂammation and changes in their lungs similar to lung ﬁbrosis,
uggesting a role for miR-155 in the immune system. Immunizedelopmental Biology 21 (2010) 774–780
Mir155 were not protected against Salmonella typhimurium, indi-
cating a lack of protective immunity. Indeed, B and T cell responses
are reduced in the Mir155 knockout, and miR-155 is implicated in
Th1 and Th2 cell development and dendritic cell function [20,47].
Mice lacking miR-375 show abnormal glucose homeostasis and
pancreatic  and  cell numbers [48].
Many microRNAs are located in the introns of coding genes.
Almost 200 of these genes were experimentally disrupted before it
was appreciated that they harboured a microRNA [49]. In at least
one case, the knockout of the Egﬂ7 locus, the vascular phenotype
and extensive embryonic lethality observed in the mutants has
been shown to result from the concomitant disruption of miR-126Fig. 2. Scanning electron microscopy of diminuendo homozygote and heterozygote
hair cells at 5 days old. (A–C) Outer hair cells of wildtype (A), heterozygote (B) and
homozygote (C) mice at 5 days old. Heterozygote hair cells appear indistinguishable
from wildtype hair cells at this early stage, but homozygote hair cells show ectopic
stereocilia and disorganisation. Scale bars =5m.
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ir208a and Mir208b, which are located in introns of Myh6 and
yh7 respectively and are differentially expressed in parallel with
heir host gene expression inmouse heart, suggesting that themiR-
As are processed from the intronic transcript rather than being
ranscribed as a separate RNA [40,41].
. Conditional knockouts reveal global microRNA
equirements
Dicer knockouts have also contributed to the association of
icroRNAs with disease by effectively knocking out all microRNAs
n the targeted cells. Mice lacking Dicer expression in the Purkinje
ells of the brain develop ataxia and degeneration of the Purkinje
ells [52], and loss of Dicer in excitatory forebrain neurons leads to
icrocephaly among other neural defects [53]. Conditional knock-
ut of Dicer in the podocytes of the kidney causes cytoskeletal
isorganisation of the podocytes, resulting in progressive glomeru-
onephritis and death of the mutant mice by 6 weeks after birth
54]. Inactivation of Dicer in the retina, using a transgene which
esults in a mosaic pattern of Dicer-expressing cells next to Dicer-
ull cells, caused retinal degeneration [55]. Knocking out Dicer in
he developing mouse liver results in hepatocyte proliferation and
poptosis, and promotes hepatocarcinogenesis [56], while loss of
icer in the pancreas leads to a severe reduction in  cells [57].
ultiple reproductive defects and female sterility occurs in mice
ith Dicer deleted in the developing Müllerian duct [58]. Loss of
icer in skin follicles from E14.5, which is when primary hair folli-
le development begins, results in dehydration after birth, probably
ue to the loss of epidermal barrier function. Most of the condi-
ional knockout mice die by about postnatal day (P)6, but before
eath, whisker and hair follicles are clearly abnormal, with cysts
ppearing in the epidermis [59,60]. Conditional knockout in the
air follicles of Dgcr8, which is also involved in microRNA process-
ng, results in a very similar phenotype, conﬁrming thatmicroRNAs
re important for skin development [61]. Conditional Dgcr8 elimi-
ation in cardiomyocytes led to dilated cardiomyopathy and early
eath [62].
Conditional knockouts of Dicer have been made to study the
ffects of total microRNA loss in the inner ear. When driven
y Pax2-Cre, Dicer expression is lost in the otocyst, kidney and
ig. 3. miR-96 conservation and expression. (A) Alignment of DNA sequences from wil
ufferﬁsh. The purple region shows the mature miRNA sequence for each species, and th
eed region is indicated by the red letter. The mature sequence is absolutely conserved b
himpanzee, orang-utan, ground squirrel, tree shrew, mouse lemur, bushbaby, cat, arma
nsembl v50; http://www.ensembl.org). (B and C) Expression of Mir96 at P5 in wildtype
art A reprinted with permission from Lewis et al. [23].elopmental Biology 21 (2010) 774–780 777
midbrain–hindbrain from about E8.5 [63]. The conditional Dicer
knockout mice showed gross malformations of the inner ear, with
loss or reduction of the lateral and anterior semicircular canals and
cristae, which house some of the vestibular sensory hair cells. The
cochlea is also misshapen, lacking coils and with only patches of
sensory hair cells which fail to organise correctly into rows of inner
and outer hair cells [64]. A hair-cell speciﬁc Dicer knockout has
also been made, using Pou4f3-Cre, which drives expression in the
cochlear andvestibular hair cells [65]. The resultingmiceweredeaf,
and had a mild balance phenotype indicative of vestibular defects.
At embryonic day 18.5 and at birth, the inner ear sensory epithelia
looked unaffected, but by postnatal day 38, the hair cells showed
signs of degeneration [66].
8. MicroRNAs in Mendelian disease
Despite demonstrations of the role of microRNAs in disease
mechanisms, mutations leading to a Mendelian disease have
been harder to ﬁnd. Single nucleotide polymorphisms have been
described in human microRNA precursor sequences but without
anyobviousassociationwithdisease [67,68].Now, three singlebase
pair changes inmiR-96, two inhumansandone inmouse, havebeen
described associated with progressive hearing loss [23,69].
Mir96, Mir182 and Mir183 are located close to each other in an
intergenic region on chromosome 6 in the mouse and are thought
to be transcribed together. They are expressed in the sensory hair
cells of the inner ear, both the inner and outer cochlear hair cells,
which are located in the spiral organ of Corti and detect sound, and
in the vestibular hair cells, which detect gravity and motion [70].
8.1. Diminuendo: a single base pair substitution in miR-96
N-ethyl-N-nitrosurea (ENU) is a powerful mutagen that intro-
duces single base pair mutations to the genome at random
locations. In a screen for dominantly inherited deafness, the
offspring of ENU-mutagenised males were tested for hearing
impairment [71], and one of the resulting mice, presumably a het-
erozygote, demonstrated progressive hearing loss between 4 and 6
weeks old.Mice homozygous for themutation, named diminuendo
(Dmdo), were profoundly deaf and exhibited circling behaviour,
dtype mouse, diminuendo homozygote, rat, human, platypus, frog, zebraﬁsh and
e bracket delineates the seed region critical for target binding. The mutation in the
etween the species shown, and also between cow, dog, horse, macaque, opossum,
dillo, tenrec, medaka, rabbit, stickleback and tetraodon (sequences obtained from
(B) and homozygote (C). Hair cells are marked by arrowheads. Scale bars =10m.
778 M.A. Lewis, K.P. Steel / Seminars in Cell & Developmental Biology 21 (2010) 774–780
Fig. 4. Hypergeometric analysis ofmicroarraydata comparingdiminuendohomozygote towildtypeat4daysold. (A)Microarrayanalysis showingenrichmentanddepletionof
heptamers in3′UTRsusingSylamer. The x-axis represents the sortedgene list frommostupregulated (left) tomostdownregulated (right). They-axis shows thehypergeometric
signiﬁcance for enrichment or depletion of heptamers in 3′UTRs of the genes under consideration when compared to the 3′UTRs in the complementary gene set. Positive
values indicate enrichment (−log10(P-value)) and negative values depletion (log10(P-value)). Any heptamers which are present more often than would be expected will
s present less often than would be expected will stand out below the signiﬁcance line on
t ced by the concatenation of its orthologous 3′UTRs in human and rat. The seed match
f in A. In contrast, the enrichment of the miR-96 diminuendo mutant binding sites in the
d mission from Lewis et al. [23].
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Fig. 5. Ocm, Slc26a5, Gﬁ1, Ptprq and Pitpnm1 in diminuendo. (A) Quantitative real-
time PCR on cDNA generated from normalised RNA from the organs of Corti of
4-day-old littermates. Ocm, Slc26a5 (prestin), Ptprq, Pitpnm1 and Gﬁ1 are down-tand out above the signiﬁcance line (adjusted P-value =0.01), and any which are
he negative axis. (B) The same analysis as in A, where each 3′UTR has been repla
or the wildtype miR-96 shows similar enrichment as compared with the analysis
ownregulated genes is barely above background (dotted line). Reprinted with per
ndicating vestibular dysfunction. Scanning electron microscopy at
weeks old showedboth outer and inner hair cellsweremisshapen
nd disorganised in the heterozygotes, while in homozygotes, hair
ells had degenerated almost entirely. Earlier in development,
omozygote hair cells were present but were abnormal in appear-
nce, with ectopic stereocilia (Fig. 2) [23].
The mutant phenotype was mapped to a 4.96Mb interval on
hromosome 6, and exons were sequenced from wildtype and
omozygote DNA to locate the mutation. A single A>T base pair
ubstitution was found in the seed region of Mir96, the region
hich is crucial for microRNA-target binding [72]. This nucleotide,
nd indeed, the entire microRNA sequence, is conserved between
uman, mouse, rat and ﬁsh (Fig. 3A). Expression of the mutant
icroRNA appears unaltered, at least spatially; miR-96, miR-182
nd miR-183 are all detected in wildtype and diminuendo mutant
air cells during the ﬁrst few days after birth (Fig. 3B and C) [23].
.2. Effects of the diminuendo mutation on gene expression
If the seed region is important for binding to the target sequence
n a messenger RNA, such a mutation is likely to both lose repres-
ion of normal targets and gain repression of novel targets. In order
o test this, a microarray was performed on RNA from the 4-day-
ld organ of Corti of homozygousmutants comparedwithwildtype
ontrols, and 96 transcripts were found to be signiﬁcantly affected.
Sylamer analysis [73] was performed on data from the entire
icroarray to detect any enrichment of heptamer sequences in
ranscripts organised in order of degree of up- or downregulation
Fig. 4). Among the upregulated genes, the heptamer complemen-
ary to thewildtype seed regionwas signiﬁcantly enriched, and this
nrichmentwas also observedwhen the analysis was run using the
uman orthologues of themouse genes in themicroarray, implying
onservation, and therefore function. Among the downregulated
enes, the heptamer complementary to the mutant seed region
as enriched, but this enrichment was barely conserved with the
uman orthologues, which is to be expected, because the mutant
ite isnotanaturallyoccurring functional sequenceandhence isnot
regulated in homozygotes. Error bars represent standard deviation. Quantities
normalised to Hprt1 levels; Ngfr is expressed in support cells adjacent to hair
cells [80] and was used to assess the quantity of sensory material. Three animals
were used per genotype and DNA from each was run in triplicate. (B–E) Location of
oncomodulin (B and C) and prestin (D and E) in 5-day-old wildtype (B and D) and
homozygote (C and E) littermates. Scale bars =10m.
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ikely to be conserved through selective pressure [23]. The results
f this analysis demonstrate that (a) hundreds of genes are targeted
y miR-96, (b) the mutant miR-96 targets new transcripts, and (c)
iR-96 has an impact on mRNA levels in addition to any effects it
ay have on protein translation.
Among the genes that were most downregulated in the dimin-
endo mutant inner ear were Slc26a5 (prestin), Ocm, Pitpnm1, Gﬁ1
nd Ptprq. Changes in expression of these ﬁve genes were ver-
ﬁed by RT-PCR and by immunohistochemistry (Fig. 5). All ﬁve
re strongly and speciﬁcally expressed in the hair cells of wild-
ype mice, and Ptprq, Gﬁ1 and Slc26a5 are known to be important
or development and function of hair cells because mice null for
ach gene exhibit hair cell degeneration and deafness [74–77]. The
act that all ﬁve genes were downregulated but do not bear the
utant target sequence means that they must be downstream of
cascade of regulation which is headed by miR-96. The primary
arget or targets of miR-96 in the inner ear have not yet been
iscovered [23].
The diminuendo mutation is the ﬁrst ENU-induced mutation in
microRNA, and the ﬁrst microRNA to be associated with deaf-
ess.miR-96mutations have also been associatedwith progressive
eafness in two human families [69]. The microRNA exerts its
ffects upon a range of genes, as seen by the Sylamer analysis, and
he results of its action include marked downregulation of several
enes important in hair cell development and function. As such, it
s a prime example of microRNA function in both development and
isease.
. Conclusion
Since the ﬁrst microRNA was identiﬁed 17 years ago, miRNAs
ave become an acknowledged part of the machinery of gene reg-
lation, and their roles in multiple systems and cell types are still
eing discovered and characterised. Their importance is evident
rom thephenotypes of knockout andmutantmice, and the numer-
us studies comparing expressionproﬁles offer an indicationof just
owmanymicroRNAsmay be required by each cell type for correct
evelopment and function. Themouse is an important organism for
hiswork, and it is to be expected that futuremicroRNA studieswill
ffer even more insights into the intricacies of development, and
opefully new therapeutic targets for treating disease.
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